Forward Pharma (FWP) Tops Q4 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Oracle shares drop on AI spending concerns and Microsoft criticism
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Forward Pharma Reports Fourth Quarter and Year End 2015 Financial and Operational Results
April 12, 2016 4:15 PM EDTCOPENHAGEN, Denmark, April 12, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP) (We or Forward or the Company), today reported financial results for the fourth quarter and year ended December 31, 2015. Net loss for the fourth quarter and year ended December 31, 2015 was $9.6 million and $37.0 million, respectively. Loss per share for the fourth quarter and year ended December 31, 2015 was $0.20 and $0.79, respectively. On a non-GAAP basis, after removing the effect of non-cash income and expense items, our fourth quarter and year ended 2015 net loss would have been $8.4 million and $35.4 million, or $0.18 and $0.76 per share, respectively. As of December 31, 2015, the Company... More



